Pamlab controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
VSL#3 formulation and advertising litigation
ExeGi Pharma LLC and Claudio De Simone brought legal claims involving Alfasigma USA and related parties over alleged false advertising and rights associated with VSL#3. The dispute concerned whether a later formulation sold under the VSL#3 name was materially different from the De Simone formulation associated with earlier scientific evidence. Related scientific commentary highlighted possible patient-safety and evidentiary issues when probiotic formulations change without clear communication.